Advertisement

Angiogenesis Associated with Visceral and Subcutaneous Adipose Tissue in Severe Human Obesity

  1. Séverine Ledoux (severine.ledoux{at}lmr.aphp.fr)1,2,
  2. Isabelle Queguiner1,
  3. Simon Msika2,
  4. Sophie Calderari1,
  5. Pierre Rufat3,
  6. Jean-Marie Gasc1,
  7. Pierre Corvol1 and
  8. Etienne Larger1
  1. (1) INSERM U833, Chaire de Médecine Expérimentale, Collège de France, Paris, France
  2. (2) Centre de l'obésité, Hôpital Louis Mourier, AP-HP, Faculté de Médecine Xavier Bichat, Université Paris 7, Paris, France
  3. (3) Unité MSI-Département de Biostatistique, santé publique et information médicale, Groupe Hospitalier Pitié-Salpetrière, AP-HP, Paris, France

    Abstract

    Objective: the expansion of adipose tissue is linked to the development of its vasculature. However, the regulation of adipose tissue angiogenesis in humans has not been extensively studied. Our aim was to compare the angiogenesis associated with SAT and VAT from the same obese patients in an in vivo model.

    Methods: adipose tissue samples from visceral (VAT) and subcutaneous (SAT) sites, obtained from 36 obese patients (mean BMI = 46.5 kg/m2) during bariatric surgery, were layered on chick chorio-allantoïc membrane (CAM).

    Results: both SAT and VAT expressed angiogenic factors, without significant difference for VEGF expression. Adipose tissue layered on CAM stimulated angiogenesis. Angiogenic stimulation was macroscopically detectable, with engulfment of the samples, in 39 % and was evidenced by angiography in 59 % of the samples. A connection between CAM and adipose tissue vessels was evidenced by immunohistochemistry, with recruitment of both avian and human endothelial cells. The angiogenic potency of adipose tissue was not related to its localization (with an angiogenic stimulation in 60% of SAT samples and 61 % of VAT samples), or to adipocyte size or inflammatory infiltrate assessed in adipose samples prior to the graft on CAM. Stimulation of angiogenesis by adipose tissue was nearly abolished by Bevacizumab, which specifically targets human VEGF.

    Conclusion: we have established a model to study the regulation of angiogenesis by human adipose tissue. This model highlighted the role of VEGF in angiogenesis in both SAT and VAT.

    Footnotes

      • Received December 22, 2007.
      • Accepted September 16, 2008.
    Advertisement